Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)

BACKGROUND: Hypertension and type 2 diabetes are common co-morbidities. Preliminary studies suggest that thiazolidinediones reduce blood pressure (BP). We therefore used ambulatory BP to quantify BP lowering at 6–12 months with rosiglitazone used in combination with metformin or sulfonylureas compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Komajda, Michel, Curtis, Paula, Hanefeld, Markolf, Beck-Nielsen, Henning, Pocock, Stuart J, Zambanini, Andrew, Jones, Nigel P, Gomis, Ramon, Home, Philip D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390513/
https://www.ncbi.nlm.nih.gov/pubmed/18435852
http://dx.doi.org/10.1186/1475-2840-7-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390513/
https://www.ncbi.nlm.nih.gov/pubmed/18435852
http://dx.doi.org/10.1186/1475-2840-7-10

Ejemplares similares